Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan R Targan

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
Immunity|December 16, 2018
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during ColitisJim G Castellanos, Viola Woo, Monica Viladomiu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Reduced expression of COVID-19 host receptor, <i>ACE2</i> is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's diseaseAlka A Potdar, Shishir Dube, Takeo Naito, et al.
Gastroenterology|January 30, 2007
NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relativesShane M Devlin, Huiying Yang, Andrew Ippoliti, et al.
Mucosal Immunology|July 11, 2018
Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiomeNoam Jacob, Jonathan P Jacobs, Kotaro Kumagai, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 3, 2023
DR3 Regulates Intestinal Epithelial Homeostasis and Regeneration After Intestinal Barrier InjuryYosuke Shimodaira, Shyam K More, Hussein Hamade, et al.
Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.
Mucosal Immunology|January 9, 2019
A role for BATF3 in T<sub>H</sub>9 differentiation and T-cell-driven mucosal pathologiesMasato Tsuda, Hussein Hamade, Lisa S Thomas, et al.
Inflammatory Bowel Diseases|September 18, 2010
Genetic predictors of medically refractory ulcerative colitisTalin Haritunians, Kent D Taylor, Stephan R Targan, et al.
Gastroenterology|November 8, 2020
Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel DiseaseAlka A Potdar, Shishir Dube, Takeo Naito, et al.
Gastroenterology|May 25, 2018
Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel DiseasesFlorent Clerc, Mislav Novokmet, Viktoria Dotz, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Immunity|December 16, 2018
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during ColitisJim G Castellanos, Viola Woo, Monica Viladomiu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Reduced expression of COVID-19 host receptor, <i>ACE2</i> is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's diseaseAlka A Potdar, Shishir Dube, Takeo Naito, et al.
Gastroenterology|January 30, 2007
NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relativesShane M Devlin, Huiying Yang, Andrew Ippoliti, et al.
Mucosal Immunology|July 11, 2018
Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiomeNoam Jacob, Jonathan P Jacobs, Kotaro Kumagai, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 3, 2023
DR3 Regulates Intestinal Epithelial Homeostasis and Regeneration After Intestinal Barrier InjuryYosuke Shimodaira, Shyam K More, Hussein Hamade, et al.
Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.
Mucosal Immunology|January 9, 2019
A role for BATF3 in T<sub>H</sub>9 differentiation and T-cell-driven mucosal pathologiesMasato Tsuda, Hussein Hamade, Lisa S Thomas, et al.
Inflammatory Bowel Diseases|September 18, 2010
Genetic predictors of medically refractory ulcerative colitisTalin Haritunians, Kent D Taylor, Stephan R Targan, et al.
Gastroenterology|November 8, 2020
Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel DiseaseAlka A Potdar, Shishir Dube, Takeo Naito, et al.
Gastroenterology|May 25, 2018
Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel DiseasesFlorent Clerc, Mislav Novokmet, Viktoria Dotz, et al.
Pageof 19